Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 805-172-8 | CAS number: 65646-25-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 13 August 2015- 8th September 2015
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 015
- Report date:
- 2015
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- 1,2-dipropyl cyclohexane-1,2-dicarboxylate
- EC Number:
- 805-172-8
- Cas Number:
- 65646-25-5
- Molecular formula:
- C14 H24 O4
- IUPAC Name:
- 1,2-dipropyl cyclohexane-1,2-dicarboxylate
- Test material form:
- other: Liquid
- Details on test material:
- Identification: CHP
Alternative name: DNPH-100
Chemical name: Cyclohexane-1,2-dicarboxylic n-propyl ester
CAS number: 65646-25-5
Intended use: Chemical process regulator
Appearance: Colourless liquid
Storage conditions: Room temperature in the dark
Supplier: Sponsor
Lot number: ST111209
Expiry date: End of December 2016
Purity/composition: 98.6%
Sample receipt: 31 March 2015
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- other: CBA/Ca
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source:Harlan Netherlands Ltd.
- Age at study initiation: approximately eight to twelve weeks of age
- Weight at study initiation: The mice were in the weight range 17.4 to 21.3 g
- Housing:They were housed two animals per cage, in solid bottomed polycarbonate cages with a stainless steel mesh lid. Each cage contained a quantity of autoclaved wood flake bedding, additionally Nestlets and a plastic shelter were included for environmental enrichment.
- Diet (e.g. ad libitum): Standard rodent diet Harlan Teklad 2014C Diet. This diet contained no added antibiotic or other chemotherapeutic or prophylactic agent
- Water (e.g. ad libitum): Potable water taken from the public supply was freely available via polycarbonate bottles fitted with sipper tubes.
- Acclimation period: They were acclimatised to the experimental environment for at least 5 days prior to the start of the study.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 to 23°C
- Humidity (%): 40 to 70%
- Air changes (per hr): The animal room was kept at positive pressure with respect to the outside by its own supply of filtered fresh air, which was passed to atmosphere and not re-circulated.
- Photoperiod (hrs dark / hrs light): Artificial lighting was controlled to give a cycle of 12 hours continuous light and 12 hours continuous dark per 24 hours.
IN-LIFE DATES: From: Day 1 To: Day 6
Study design: in vivo (non-LLNA)
- Positive control substance(s):
- yes
- Remarks:
- Hexyl cinnamic aldehyde
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 25, 50% v/v in AOO and the test substance as supplied.
The positive control group received 25% v/v hexylcinnamic aldehyde in AOO based on previous experience at this laboratory. - No. of animals per dose:
- Preliminary investigation-Two female mice (per concentration) received a daily application of 25 micro litres for three consecutive days
Main phase- Groups of four mice were treated at one of three concentrations of the test substance. Mice received a daily application of 25 micro litres for three consecutive days. Further groups of four mice were sham dosed, received the vehicle alone or the positive control substance in the same manner. An additional sham control group was added to the main study and consisted of four mice.
In the main phase of the study, five days following the first topical application of test substance (Day 6) all mice were injected via the tail vein with 250 micro litres of phosphate buffered saline containing 3H-methyl Thymidinea (3HTdR: 80 microCi/mL) giving a nominal 20 microCi to each mouse. - Details on study design:
- RANGE FINDING TESTS:
- Compound solubility:
- Irritation:
- Lymph node proliferation response:
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: Assessment of Skin Sensitization Potential using the Local Lymph Node Assay in the Mouse (Pooled treatment group approach)
- Criteria used to consider a positive response: The test substance is regarded as a sensitizer if at least one concentration of the chemical has a SI of three or more.
TREATMENT PREPARATION AND ADMINISTRATION:
Preliminary investigation-The test substance was applied to the dorsal surface of each ear using an automatic micropipette and was spread over the entire dorsal surface of the ear using the tip of the pipette.
Main phase- The test
substance was applied to the dorsal surface of each ear using an automatic micropipette and
was spread over the entire dorsal surface of the ear using the tip of the pipette. Further groups of four mice were sham dosed, received the vehicle alone or the positive control substance in the same manner.
Sham control group-At dosing, the tip of a pipette was passed over the dorsum of the mouse ears, but no vehicle administered.
Administration of 3H-methyl Thymidine- The injection into the tail vein was carried out using a plastic syringe and needle after the mouse had been heated in a warming chamber. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
Results and discussion
- Positive control results:
- The SI for the positive control substance hexyl cinnamic aldehyde (HCA), was 6.3 which demonstrates the validity of this study.
In vivo (LLNA)
Resultsopen allclose all
- Key result
- Parameter:
- SI
- Remarks:
- As supplied
- Value:
- 5.5
- Remarks on result:
- other: The SI (test/control ratios) obtained for 25, 50% v/v and as supplied were 2.1, 1.1 and 5.5 respectively.
- Key result
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks:
- As supplied
- Value:
- 3 429.6
- Remarks on result:
- other: Please see table 1 in overall remarks and attachments.
- Key result
- Parameter:
- other: dpm/node
- Remarks:
- As supplied
- Value:
- 857.4
- Remarks on result:
- other: Please see table 2 in overall remarks and attachments.
Any other information on results incl. tables
Results -Preliminary investigation-Mortality and clinical signs-No signs of ill health or toxicity were observed during this study. Wet/greasy fur on the head was noted in both groups following each dosing occasion, this was related to unoccluded dermal administration of a liquid formulation/vehicle and not an effect of the test substance.
Dermal reactions-No erythema was observed on the ears of either mouse on Days 1 to 6.
Measurement of ear thickness-There was no evidence of an effect of treatment on ear thickness.
Body weight-There was no indication of an overt effect of treatment on body weight gain. On the basis of the results from the preliminary investigation, CHP as supplied was considered a suitable high concentration for administration in the main phase of the study.
Main phase -Mortality and clinical signs-There were no deaths and no signs of ill health or toxicity were observed during this study. Wet/greasy fur on the head was noted in all groups (except the sham dosed group) following each dosing occasion, this was related to unoccluded dermal administration of a liquid formulation/vehicle and not an effect of the test substance.
Dermal reactions-No signs of dermal irritation were seen on the ear during the study.
Body weight-There was no indication of an effect of treatment on body weight gain. Envigo: LBM0091 19 A loss in body weight was noted for four mice (Nos. A9, A20, A25and A27) over the study period, however, a small loss in body weight is not uncommon in young laboratory mice and is not considered to be an effect of treatment.
Applicant's summary and conclusion
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- CHP is regarded as a potential skin sensitizer.
- Executive summary:
Summary
The study was performed to assess the skin sensitization potential of CHP using the local lymph node assay (LLNA).
Preliminary investigations were performed at 50% v/v and the test substance as supplied with 2 mice per concentration to establish the highest concentration of test substance which did not lead to systemic toxicity or excessive local irritation. The results of preliminary investigations indicated that the test substance as supplied would be a suitable high concentration for use on the main study.
The study comprised three treated groups, each comprising four female mice receiving CHP at concentrations of 25, 50% v/v or as supplied. Similarly constituted groups were either sham dosed, received the vehicle 4:1 v/v acetone:olive oil (AOO) or positive control substance (25% v/v hexyl cinnamic aldehyde). The mice were treated by daily application of 25 µL of the appropriate concentration or control (vehicle or positive), to the dorsal surface of both ears for three consecutive days. The proliferative response of the lymph node cells (LNC) from the draining auricular lymph nodes was assessed five days following the initial application, by measurement of the incorporation of 3H-methyl Thymidine (3HTdR) by ß-scintillation counting of LNC suspensions. The response was expressed as radioactive disintegrations per minute per lymph node (dpm/node) and as the ratio of 3HTdR incorporation into LNC of test nodes relative to that recorded for control nodes (test/control ratio), termed as Stimulation Index (SI). The test substance is regarded as a sensitizer if at least one concentration of the chemical has a SI of three or more.
Results
The SI results obtained for 25, 50% v/v and as supplied were 2.1, 1.1 and 5.5 respectively which indicates that CHP showed the potential to induce skin sensitization. The SI for the positive control substance hexyl cinnamic aldehyde was 6.3, which demonstrates the validity of this study.
Conclusion
CHP is regarded as a potential skin sensitizer.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.